Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Depreciation & Amortization (CF) (2017 - 2022)

Historic Depreciation & Amortization (CF) for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $10000.0.

  • Iterum Therapeutics' Depreciation & Amortization (CF) fell 8333.33% to $10000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $84000.0, marking a year-over-year decrease of 7851.66%. This contributed to the annual value of -$5000.0 for FY2024, which is 11612.9% down from last year.
  • Per Iterum Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $10000.0 for Q4 2022, which was down 8333.33% from $19000.0 recorded in Q3 2022.
  • Over the past 5 years, Iterum Therapeutics' Depreciation & Amortization (CF) peaked at $185000.0 during Q2 2021, and registered a low of $10000.0 during Q4 2022.
  • In the last 5 years, Iterum Therapeutics' Depreciation & Amortization (CF) had a median value of $38000.0 in 2018 and averaged $46200.0.
  • In the last 5 years, Iterum Therapeutics' Depreciation & Amortization (CF) skyrocketed by 37435.9% in 2021 and then tumbled by 8594.59% in 2022.
  • Iterum Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $37000.0 in 2018, then rose by 5.41% to $39000.0 in 2019, then changed by 0.0% to $39000.0 in 2020, then soared by 53.85% to $60000.0 in 2021, then plummeted by 83.33% to $10000.0 in 2022.
  • Its last three reported values are $10000.0 in Q4 2022, $19000.0 for Q3 2022, and $26000.0 during Q2 2022.